NCT03967964View on ClinicalTrials.gov

Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 20, 2015

Primary Completion Date

July 15, 2016

Study Completion Date

July 15, 2016

Conditions
PharmacokineticsHormone Deficiency
Interventions
DRUG

Dehydroepiandrosterone 2.2 g

Vaginal ring with 2.2 grams DHEA.

DRUG

Dehydroepiandrosterone 1.5 g/Testosterone 25 mg

Vaginal ring with DHEA 1.5 grams/Testosterone 25 mg.

DRUG

Testosterone

Vaginal ring with 35 mg testosterone.

DRUG

Testosterone Topical Gel

Gel containing 1% testosterone.

DRUG

Dehydroepiandrosterone Oral Capsule

Capsule containing 25 mg DHEA

Trial Locations (1)

Unknown

Instituto de Investigación Materno Infantil (IDIMI) - Maternidad Hospital San Borja (HCSBA), Santiago

Sponsors
All Listed Sponsors
lead

Laboratorios Andromaco S.A.

INDUSTRY

NCT03967964 - Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA) | Biotech Hunter | Biotech Hunter